TY - JOUR
T1 - Glutathione is a physiologic reservoir of neuronal glutamate
AU - Koga, Minori
AU - Serritella, Anthony V.
AU - Messmer, Marcus M.
AU - Hayashi-Takagi, Akiko
AU - Hester, Lynda D.
AU - Snyder, Solomon H.
AU - Sawa, Akira
AU - Sedlak, Thomas W.
N1 - Funding Information:
Support by NIH NINDS 1K08NS057824 (TWS), NIH MH 092443 (AS), NIH MH 18501 (SHS), NIH MH 084018 (AS) and NARSAD Young Investigator Award (TWS). We thank Yukiko Lema for guidance in manuscript preparation.
Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/6/17
Y1 - 2011/6/17
N2 - Glutamate, the principal excitatory neurotransmitter of the brain, participates in a multitude of physiologic and pathologic processes, including learning and memory. Glutathione, a tripeptide composed of the amino acids glutamate, cysteine, and glycine, serves important cofactor roles in antioxidant defense and drug detoxification, but glutathione deficits occur in multiple neuropsychiatric disorders. Glutathione synthesis and metabolism are governed by a cycle of enzymes, the γ-glutamyl cycle, which can achieve intracellular glutathione concentrations of 1-10. mM. Because of the considerable quantity of brain glutathione and its rapid turnover, we hypothesized that glutathione may serve as a reservoir of neural glutamate. We quantified glutamate in HT22 hippocampal neurons, PC12 cells and primary cortical neurons after treatment with molecular inhibitors targeting three different enzymes of the glutathione metabolic cycle. Inhibiting 5-oxoprolinase and γ-glutamyl transferase, enzymes that liberate glutamate from glutathione, leads to decreases in glutamate. In contrast, inhibition of γ-glutamyl cysteine ligase, which uses glutamate to synthesize glutathione, results in substantial glutamate accumulation. Increased glutamate levels following inhibition of glutathione synthesis temporally precede later effects upon oxidative stress.
AB - Glutamate, the principal excitatory neurotransmitter of the brain, participates in a multitude of physiologic and pathologic processes, including learning and memory. Glutathione, a tripeptide composed of the amino acids glutamate, cysteine, and glycine, serves important cofactor roles in antioxidant defense and drug detoxification, but glutathione deficits occur in multiple neuropsychiatric disorders. Glutathione synthesis and metabolism are governed by a cycle of enzymes, the γ-glutamyl cycle, which can achieve intracellular glutathione concentrations of 1-10. mM. Because of the considerable quantity of brain glutathione and its rapid turnover, we hypothesized that glutathione may serve as a reservoir of neural glutamate. We quantified glutamate in HT22 hippocampal neurons, PC12 cells and primary cortical neurons after treatment with molecular inhibitors targeting three different enzymes of the glutathione metabolic cycle. Inhibiting 5-oxoprolinase and γ-glutamyl transferase, enzymes that liberate glutamate from glutathione, leads to decreases in glutamate. In contrast, inhibition of γ-glutamyl cysteine ligase, which uses glutamate to synthesize glutathione, results in substantial glutamate accumulation. Increased glutamate levels following inhibition of glutathione synthesis temporally precede later effects upon oxidative stress.
KW - Antioxidants
KW - Glutamate
KW - Glutamyl cycle
KW - Glutathione
KW - Neurons
KW - Neurotransmitter
UR - http://www.scopus.com/inward/record.url?scp=79959262849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959262849&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2011.04.087
DO - 10.1016/j.bbrc.2011.04.087
M3 - Article
C2 - 21539809
AN - SCOPUS:79959262849
VL - 409
SP - 596
EP - 602
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 4
ER -